Tivozanib hydrochloride bulk supplier for pharma manufacturers

Tivozanib Hydrochloride 0.89 mg, 1.34 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 0.89 mg, 1.34 mg

Reference Brands: Fotivda (USA/EU)

Tivozanib is an oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor used in the treatment of advanced renal cell carcinoma (RCC). It works by blocking the VEGF receptors involved in tumor angiogenesis, thereby slowing or stopping the growth of cancer cells.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Tivozanib Hydrochloride — third party manufacturing & bulk supply

Tivozanib Hydrochloride 0.89 mg, 1.34 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tivozanib Hydrochloride is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tivozanib Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tivozanib Hydrochloride →

Back to Listing

Frequently Asked Questions

Tivozanib hydrochloride is used for the treatment of advanced renal cell carcinoma (RCC) in adults, particularly in cases where the disease has progressed following other cancer therapies.

Tivozanib hydrochloride is made from the active ingredient Tivozanib, a potent and selective inhibitor of VEGF receptors, combined with hydrochloride to form its salt.

The trade name of Tivozanib hydrochloride is Fotivda.

Tivozanib hydrochloride is manufactured by AVEO Oncology and EUSA Pharma.

The generic name is Tivozanib hydrochloride.

The brand name is Fotivda.

Tivozanib hydrochloride is manufactured in countries including the United States, the United Kingdom, and Ireland by AVEO Oncology and EUSA Pharma for global cancer treatment markets.